Company / Profit Margin
Edesa Biotech, Inc. Profit Margin History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-1935.3%
FY2021
5-year range
-2267.9% / -374.7%
FY2017-FY2021
Trend
-186.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 7 years, ranging from -2657.5% in FY2015 to -374.7% in FY2017.
Based on SEC 10-K filings.
-1935.3% in FY2021 with a 5-year CAGR of +332.5%.
Improved from -2203.7% to -1935.3% over the past 3 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +268.3pp
- 5-Year Change
- +332.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2021, profit margin decreased 186.4% year-over-year.
- Peak profit margin was recorded in FY2017.
- Lowest profit margin in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -1935.3% | -186.4% |
| FY2020 | -675.8% | +69.3% |
| FY2018 | -2203.7% | -488.1% |
| FY2017 | -374.7% | +83.5% |
| FY2016 | -2267.9% | +14.7% |
| FY2015 | -2657.5% | -37.5% |
| FY2014 | -1933.0% | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026